Get the Stockscreener App
11.66
6.12%
-0.76
After Hours:
11.55
-0.11
-0.94%
Quidelortho Corp stock is traded at $11.66, with a volume of 3.18M.
It is down -6.12% in the last 24 hours and down -32.41% over the past month.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.
See More
Previous Close:
$12.42
Open:
$12.435
24h Volume:
3.18M
Relative Volume:
1.62
Market Cap:
$793.99M
Revenue:
$2.73B
Net Income/Loss:
$-1.13B
P/E Ratio:
-0.6998
EPS:
-16.6622
Net Cash Flow:
$-83.00M
1W Performance:
-3.00%
1M Performance:
-32.41%
6M Performance:
-57.40%
1Y Performance:
-57.89%
1-Day Range:
$11.58
$12.80
1-Week Range:
$11.19
$12.85
52-Week Range:
$10.86
$38.99
Quidelortho Corp Stock (QDEL) Company Profile
Name
Quidelortho Corp
Sector
Industry
Phone
(858) 552-1100
Address
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Compare QDEL vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QDEL
Quidelortho Corp
|
11.66 | 845.75M | 2.73B | -1.13B | -83.00M | -16.66 |
ABT
Abbott Laboratories
|
87.17 | 152.48B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 111.40B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 100.53B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 84.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 48.04B | 6.30B | 1.07B | 1.34B | 1.8406 |
Quidelortho Corp Stock (QDEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-07-25 | Downgrade | Citigroup | Buy → Neutral |
| May-08-25 | Upgrade | Jefferies | Hold → Buy |
| Dec-11-24 | Upgrade | Citigroup | Neutral → Buy |
| Dec-10-24 | Initiated | Jefferies | Hold |
| Sep-19-24 | Resumed | UBS | Neutral |
| Sep-05-24 | Upgrade | Craig Hallum | Hold → Buy |
| Mar-04-24 | Downgrade | UBS | Neutral → Sell |
| Feb-14-24 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-11-23 | Downgrade | Citigroup | Buy → Neutral |
| Dec-12-22 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-14-22 | Upgrade | UBS | Sell → Neutral |
| Sep-19-22 | Initiated | Citigroup | Neutral |
| Jul-20-22 | Initiated | UBS | Sell |
| Jun-17-22 | Resumed | JP Morgan | Neutral |
| Feb-22-22 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-22-21 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-12-20 | Downgrade | JP Morgan | Neutral → Underweight |
| Mar-26-20 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-23-18 | Resumed | Raymond James | Strong Buy |
| Mar-08-18 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-22-18 | Reiterated | Barclays | Overweight |
| Jan-04-18 | Upgrade | CL King | Neutral → Buy |
| Sep-19-17 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Jul-18-17 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jul-18-17 | Upgrade | William Blair | Mkt Perform → Outperform |
| Apr-25-17 | Reiterated | Canaccord Genuity | Hold |
| Feb-17-17 | Initiated | CL King | Neutral |
| Dec-16-16 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jun-13-16 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Feb-18-16 | Reiterated | Barclays | Overweight |
| Feb-09-16 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jan-08-16 | Reiterated | Canaccord Genuity | Buy |
| Dec-14-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-02-15 | Initiated | Barclays | Overweight |
| Jul-31-13 | Reiterated | Canaccord Genuity | Buy |
| Mar-03-11 | Downgrade | Wedbush | Outperform → Neutral |
View All
Quidelortho Corp Stock (QDEL) Latest News
QuidelOrtho Q1 2026 slides: revenue falls 13%, respiratory weakness pressures margins - Investing.com
QuidelOrtho (QDEL) Q1 2026 Earnings Transcript - AOL.com
QuidelOrtho (QDEL) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
Earnings call transcript: QuidelOrtho Q1 2026 results miss expectations - Investing.com
Earnings Flash (QDEL) QuidelOrtho Corporation Reports Q1 Revenue $619.8M, vs. FactSet Est of $665.2M - marketscreener.com
QuidelOrtho (NASDAQ:QDEL) Misses Q1 CY2026 Revenue Estimates - StockStory
QuidelOrtho Corp (NASDAQ:QDEL) Misses Q1 2026 Estimates, Shares Slide 2.7% - ChartMill
QuidelOrtho: Q1 Earnings Snapshot - kens5.com
Earnings Flash (QDEL) QuidelOrtho Corporation Posts Q1 Adjusted Loss $0.04 per Share - marketscreener.com
A weak respiratory season hit QuidelOrtho as its 2026 targets fell - Stock Titan
QuidelOrtho (NASDAQ: QDEL) trims 2026 outlook after Q1 revenue and margin decline - Stock Titan
QuidelOrtho (QDEL) To Report Earnings Tomorrow: Here Is What To Expect - Yahoo Finance
QuidelOrtho Corp. Hits New 52-Week Low at $10.86 Amid Ongoing Struggles - Markets Mojo
Earnings preview: QuidelOrtho (QDEL) Q1 earnings expected to decline - MSN
LEX Diagnostics acquired by QuidelOrtho Corporation for $100m six years after launch - Cambridge Independent
Earnings Preview: QuidelOrtho to Report Financial Results Post-market on May 05 - Moomoo
QuidelOrtho (QDEL) price target decreased by 18.10% to 29.38 - MSN
Vanguard holds 4,088,168 shares of QuidelOrtho (NASDAQ: QDEL) - Stock Titan
QuidelOrtho (QDEL) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
Earnings Preview: QuidelOrtho (QDEL) Q1 Earnings Expected to Decline - Yahoo Finance
QuidelOrtho to discontinue Savanna platform development - MSN
Estuary Capital Management LP's QuidelOrtho Corp(QDEL) Holding History - GuruFocus
Why is QuidelOrtho (QDEL) down 24.5% since last earnings report? - MSN
QuidelOrtho Corp (QDEL) Shares Surge 6.1% -- What GF Score of 60 Tells Investors - GuruFocus
[ARS] QuidelOrtho Corp SEC Filing - Stock Titan
[DEF 14A] QuidelOrtho Corp Definitive Proxy Statement - Stock Titan
TTP Group sells LEX Diagnostics to QuidelOrtho to scale PCR tech - MSN
QuidelOrtho (QDEL) drops 20% after-hours on Wednesday—what's going on? - MSN
Why diagnostics names CareDx and QuidelOrtho just diverged - MSN
QuidelOrtho completes $100m acquisition of LEX Diagnostics from TTP - Business Weekly
QuidelOrtho, MIND Technology, Southern First Bancshares and other big stocks moving lower in Thursday's pre-market session - MSN
QuidelOrtho Corp. Opens with 5.51% Gain Amid Ongoing Financial Challenges - Markets Mojo
QuidelOrtho (QDEL) COO reports RSU vesting and tax share withholding - Stock Titan
QuidelOrtho(QDEL.US) 10% Shareholder Sells US$5.72 Million in Common Stock - 富途牛牛
QuidelOrtho (NASDAQ:QDEL) Reaches New 12-Month LowWhat's Next? - MarketBeat
Understanding and Addressing Syphilis Trends – and What’s Being Missed - The Malaysian Reserve
QuidelOrtho stock sinks to 52-week lowhere's why - MSN
Understanding and Addressing Syphilis Trendsand What's Being Missed – Company Announcement - Financial Times
QuidelOrtho (NASDAQ:QDEL) Shares Down 7.1%Here's What Happened - MarketBeat
UK: QuidelOrtho aquires LEX Diagnostics from TTP Group for US$100m - Investors in Healthcare
QuidelOrtho acquires molecular diagnostics firm LEX Diagnostics By Investing.com - Investing.com India
QuidelOrtho completes LEX Diagnostics buy for $100 million By Investing.com - Investing.com India
QuidelOrtho Corp. Hits Day Low of $11.63 Amid Price Pressure - Markets Mojo
Quidelortho Corp Stock (QDEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):